Veterinary clinics around the world are embracing new technologies to enhance diagnostic accuracy, streamline patient care, and optimise clinic operations. One of the most exciting developments in this space is the adoption of HT Vista, a non-invasive, AI-powered cancer screening tool for dogs.

A newly released survey by HT Vet, featured in Business Insider, confirms what many clinics have already experienced firsthand: HT Vista is changing how vets identify and manage suspicious lumps and bumps, leading to earlier intervention, greater diagnostic confidence and significant increases in surgical procedures.

A 40% Increase in Mass Removal Surgeries

The independent survey monitored ten veterinary clinics across the US,UK and Israel, evaluating performance over a period of 3 to 6 months before and after introducing HT Vista into routine workflow. Despite having consistent caseloads, every clinic recorded an increase in mass removals and biopsies. In fact, practices using HT Vista saw a 40% average increase in mass removal surgeries, with some reporting rises of up to 200%.

These increases occurred without any growth in the number of patients presenting with lumps. Clinics were simply able to take faster action and make clearer decisions, leading to more proactive treatment plans and ultimately more surgical procedures performed.

Clearer, Faster Decisions for Vets and Pet Owners

HT Vista’s scan takes just 40 seconds and uses proprietary Heat Diffusion Imaging technology to provide a Cancer Risk Score. This score comes with 90% sensitivity, a 98% negative predictive value, and alerts when specificity surpasses 90%. This gives clinicians the confidence to determine next steps quickly and accurately. When a scan shows low risk, pet owners can feel reassured. When it shows high risk, further diagnostics or surgical removal can be immediately discussed.

As Dr Ohad Barnea, Clinical Director at Tenafly Veterinary Center, explained:

“If I get a high cancer risk result, I recommend diagnostics or removal more urgently. If it’s a low cancer risk result, we might do a minor surgical removal with local anaesthesia, preventing benign tumours from becoming problematic. HT Vista provides critical guidance for the next steps, and the clients love the clarity and assurance it gives them.”

Better Outcomes, Faster Treatments

The reduction in the ‘wait and see’ approach has been a game-changer. Instead of monitoring lumps over time and delaying critical decisions, clinic scan now act with confidence. This shortens the time between detection and treatment, improves patient outcomes and gives pet owners greater peace of mind.

Measurable Return on Investment

The survey data and supporting feedback from clinics indicate that HT Vista can lead to significant revenue gains. Most clinics adopting the device have seen measurable returns within 4 to 6 months, driven by increases in diagnostic and surgical procedures. HT Vista also helps reduce unnecessary referrals and streamlines in-clinic decision-making, improving the financial health of veterinary businesses.

Expanding Global Access

HT Vet is committed to bringing HT Vista into more veterinary clinics worldwide. With strategic distribution partnerships, such as the recent agreement with Patterson Veterinary in the United States, HT Vista is becoming more accessible than ever. Clinics in Australia now have the opportunity to lead the way in advanced, non-invasive cancer detection and elevate their standard of care.

HT Vista is more than just a screening tool. It empowers clinics to deliver faster, smarter and more informed care while unlocking clinical and commercial value.

To learn more or request a demonstration, visit VetEdge.